Stockreport

ESMO 2024: Exact Sciences unveils results from cancer algorithm trial [Yahoo! Finance]

Exact Sciences Corporation  (EXAS) 
Last exact sciences corporation earnings: 2/11 04:05 pm Check Earnings Report
PDF cancer (CRC) screening test algorithm showed a sensitivity of 88% for colorectal cancer and 31% for advanced precancerous lesions at 90% specificity. Taking to the sta [Read more]